Stocks & Financial News
Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts
Cascades Reports Third Quarter 2026 Results
KINGSEY FALLS, QC, Nov. 5, 2026 /CNW/ -- Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended September 30, 2026.
Q3 2026 Highlights
- Sales of $1,267 million (compared with $1,219 million in Q2 2026 and $1,238 million in Q3 2025);
- Operating income of $78 million (compared with $58 million in Q2 2026 and $73 million in Q3 2025);
- Net earnings per common share of $0.30 (compared with $0.21 in Q2 2026 and $0.29 in Q3 2025);
- Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA (A))1 of $162 million (compared with $140 million in Q2 2026 and $159 million in Q3 2025);
- Adjusted net earnings per common share1 of $0.33 (compared with $0.24 in Q2 2026 and $0.38 in Q3 2025);
- Net debt1 of $1,863 million as of September 30, 2026 (compared with $1,879 million as of June 30, 2026). Net debt to EBITDA (A) ratio1 of 3.2x, down from 3.3x as of June 30, 2026;
- Total capital expenditures of $47 million in Q3 2026, compared to $40 million in Q2 2026 and $30 million in Q3 2025. The Corporation's 2026 forecasted capital expenditures before disposals will be in a range of $150 million to $175 million.
- The Company generated $11 million in asset sale proceeds during the third quarter, bringing total proceeds to $165 million for the 2025 - 2026 period. The Company's objective of generating $230 million is progressing well and is now expected to be achieved in early 2027.
Hugues Simon, President and CEO, commented: "Our third quarter results were in line with our expectations despite significant headwinds from ongoing tariff-related disruptions, cost inflation and continued uncertainty in the economic environment. Our Packaging segment faced headwinds from higher raw material and transportation costs, combined with tariff impacts of approximately $4 million, which more than offset the benefits of our operational and pricing improvement initiatives. Packaging volumes remained generally in line with our assumptions, although customer demand remained uneven across certain end markets. In Tissue, results came in ahead of our expectations. Realization of previously announced selling price increases largely offset ongoing inflationary pressures and lower volume in our Away-from-Home business, while our continued focus on productivity and cost reduction initiatives supported profitability. Corporate activities performed better than anticipated, reflecting the benefits of cost reduction initiatives and an improved contribution from our Recovery and Recycling operations. Overall, we remained disciplined in managing the aspects of the business within our control, while continuing to strengthen the resilience and efficiency of our operating platform. Our financial position remained stable during the quarter, supported by prudent capital allocation and continued focus on debt reduction and cash generation."
Discussing near-term outlook, Mr. Simon commented, "Looking ahead, we remain prudent regarding demand and inflationary costs, given the uncertain macroeconomic environment and the continued impact of tariffs on customer purchasing patterns. With market conditions remaining challenging, we expect consolidated fourth quarter results to be slightly lower sequentially, and anticipate continued pressure from raw material costs, transportation expenses and tariff-related impacts. Nevertheless, the ongoing realization of price increases, ongoing profitability improvement initiatives and contributions from our operational optimization efforts are expected to continue to help mitigate these pressures. In this environment, our priorities remain unchanged: maintaining disciplined capital management, enhancing productivity across our asset network, optimizing our customer portfolio and executing initiatives that strengthen the long-term resilience and competitiveness of the business."
1 Some information represents non-IFRS Accounting Standards Financial measures, other financial measures or non-IFRS Accounting Standards ratios which are not standardized under IFRS Accounting Standards and therefore might not be comparable to similar financial measures disclosed by other corporations. Please refer to the "Supplemental Information on Non-IFRS Accounting Standards Measures and Other Financial Measures" section for a complete reconciliation. |
Financial Summary
Selected consolidated information
(in millions of Canadian dollars, except amounts per common share) (unaudited) | Q3 2026 | Q2 2026 | Q3 2025 |
Sales | 1,267 | 1,219 | 1,238 |
As Reported | |||
Operating income | 78 | 58 | 73 |
Net earnings | 30 | 21 | 29 |
per common share (basic) | $0.30 | $0.21 | $0.29 |
Adjusted1 | |||
Earnings before interest, taxes, depreciation and amortization (EBITDA (A)) | 162 | 140 | 159 |
Net earnings | 34 | 24 | 39 |
per common share (basic) | $0.33 | $0.24 | $0.38 |
Margin (EBITDA (A) / Sales) | 12.8 % | 11.5 % | 12.8 % |
Net debt1 | 1,863 | 1,879 | 2,023 |
Net debt / EBITDA (A) ratio1 | 3.2x | 3.3x | 3.6x |
Segmented sales
(in millions of Canadian dollars) (unaudited) | Q3 2026 | Q2 2026 | Q3 2025 |
Packaging Products | 807 | 772 | 797 |
Tissue Papers | 415 | 409 | 412 |
Inter-segment sales, Corporate, Recovery and Recycling activities | 45 | 38 | 29 |
Sales | 1,267 | 1,219 | 1,238 |
Segmented operating income (loss)
(in millions of Canadian dollars) (unaudited) | Q3 2026 | Q2 2026 | Q3 2025 |
Packaging Products | 64 | 68 | 73 |
Tissue Papers | 32 | 20 | 30 |
Corporate, Recovery and Recycling activities | (18) | (30) | (30) |
Operating income | 78 | 58 | 73 |
Segmented EBITDA (A)1
(in millions of Canadian dollars) (unaudited) | Q3 2026 | Q2 2026 | Q3 2025 |
Packaging Products | 126 | 120 | 136 |
Tissue Papers | 47 | 35 | 46 |
Corporate, Recovery and Recycling activities | (11) | (15) | (23) |
EBITDA (A)1 | 162 | 140 | 159 |
1 Please refer to the "Supplemental Information on Non-IFRS Accounting Standards Measures and Other Financial Measures" section for a complete reconciliation. |
Analysis of results for the three-month period ended September 30, 2026 (compared to the same period last year)
The Corporation's third quarter sales of $1,267 million increased by $29 million, or 2%, compared with the same period last year. This increase reflects consolidated net benefits of $42 million from higher average selling prices, a favourable sales mix of $24 million and a favourable average foreign exchange rate of $13 million. However, these factors were partially offset by a $50 million impact from lower volumes, primarily in the Tissue Papers segment, as well as the effects of business closures and asset dispositions completed in previous quarters within the Packaging Products segment.
The third quarter EBITDA (A)1 totaled $162 million, an increase of $3 million, or 2%, from the $159 million generated in the same period last year. This increase was driven by higher average selling prices and cost reduction initiatives across the Corporation's businesses. These impacts were partially offset by higher raw material, transportation and energy costs.
The main specific items, before income taxes, that impacted our operating income and/or net earnings for the third quarter of 2026 were:
- $7 million of impairment on equipment related to a decision to discontinue a product line and for a recovery facility in Canada (operating income and net earnings);
- $8 million of gains related to the sale of the real estate from the 2025 closed recovery facility in Canada (operating income and net earnings);
- $3 million of an environmental cost related to a previously closed plant in the United States (operating income and net earnings);
- $4 million of restructuring costs related to a previously closed plant in the United States and corporate organizational changes (operating income and net earnings);
- $1 million of gains related to the sale of an investment in a non-significant associate (net earnings).
For the three-month period ended September 30, 2026, the Corporation posted net earnings of $30 million, or $0.30 per common share, compared to net earnings of $29 million, or $0.29 per common share, in the same period of 2025. On an adjusted basis1, the Corporation posted net earnings of $34 million in the third quarter of 2026, or $0.33 per common share, compared to net earnings of $39 million, or $0.38 per common share, in the same period of 2025.
1 Please refer to the "Supplemental Information on Non-IFRS Accounting Standards Measures and Other Financial Measures" section for a complete reconciliation. |
Dividend on common shares and normal course issuer bid
The Board of Directors of Cascades declared a quarterly dividend of $0.12 per common share to be paid on December 3, 2026 to shareholders of record at the close of business on November 19, 2026. This dividend is an "eligible dividend" as per the Income Tax Act (R.C.S. (1985), Canada). During the third quarter of 2026, Cascades purchased no common shares for cancellation.
2026 Third Quarter Results Conference Call Details
Management will discuss the 2026 third quarter financial results during a conference call today at 9:00 a.m. ET. The call can be accessed by dialing 1-800-990-4777 (international 1-289-819-1299). The conference call, including the investor presentation, will be broadcast live on the Cascades website (www.cascades.com) under the "Investors" section. A replay of the call will be available on the Cascades website and may also be accessed by phone until December 5, 2026 by dialing 1-888-660-6345 (international 1-289-819-1450), access code 80426 #.
Founded in 1964, Cascades offers sustainable, innovative and value-added packaging, hygiene and recovery solutions. The company employs approximately 8,900 women and men across a network of 60 operating facilities, including 17 Recovery and Recycling facilities which are part of Corporate Activities and joint ventures managed by the Corporation, in North America. Driven by its participative management, half a century of experience in recycling, and continuous research and development efforts, Cascades continues to provide innovative products that customers have come to rely on, while contributing to the well-being of people, communities and the entire planet. Cascades' shares trade on the Toronto Stock Exchange under the ticker symbol CAS. Certain statements in this release, including statements regarding future results and performance, are forward-looking statements based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for the Corporation's products, increases in raw material costs, fluctuations in selling prices and adverse changes in general market and industry conditions and other factors.
CONSOLIDATED BALANCE SHEETS
(in millions of Canadian dollars) (unaudited) | September 30, | December 31, |
Assets | ||
Current assets | ||
Cash and cash equivalents | 103 | 48 |
Accounts receivable | 530 | 426 |
Current income tax assets | 16 | 12 |
Inventories | 737 | 661 |
Current portion of financial assets | 6 | 4 |
Current portion of other assets | 3 | — |
1,395 | 1,151 | |
Long-term assets | ||
Investments in associates and joint ventures | 66 | 66 |
Property, plant and equipment | 2,613 | 2,649 |
Intangible assets with finite useful life | 26 | 30 |
Financial assets | 2 | 5 |
Other assets | 109 | 107 |
Deferred income tax assets | 179 | 174 |
Goodwill and other intangible assets with indefinite useful life | 501 | 491 |
4,891 | 4,673 | |
Liabilities and Equity | ||
Current liabilities | ||
Trade and other payables | 792 | 697 |
Current income tax liabilities | 5 | 4 |
Current portion of long-term debt | 76 | 70 |
Current portion of provisions for charges | 11 | 8 |
Current portion of financial liabilities and other liabilities | 40 | 28 |
924 | 807 | |
Long-term liabilities | ||
Long-term debt | 1,890 | 1,874 |
Provisions for charges | 58 | 58 |
Financial liabilities | 13 | 8 |
Other liabilities | 63 | 74 |
Deferred income tax liabilities | 105 | 97 |
3,053 | 2,918 | |
Equity | ||
Capital stock | 631 | 619 |
Contributed surplus | 16 | 17 |
Retained earnings | 1,098 | 1,042 |
Accumulated other comprehensive income | 64 | 43 |
Equity attributable to Shareholders | 1,809 | 1,721 |
Non-controlling interests | 29 | 34 |
Total equity | 1,838 | 1,755 |
4,891 | 4,673 |
CONSOLIDATED STATEMENTS OF EARNINGS
For the 3-month periods | For the 9-month periods | |||
(in millions of Canadian dollars, except per common share amounts and | 2026 | 2025 | 2026 | 2025 |
Sales | 1,267 | 1,238 | 3,611 | 3,579 |
Supply chain and logistics | 780 | 744 | 2,210 | 2,125 |
Wages and employee benefits expenses | 272 | 269 | 806 | 824 |
Depreciation and amortization | 78 | 74 | 226 | 215 |
Maintenance and repair | 58 | 62 | 176 | 193 |
Other operational costs (revenues) | (5) | 4 | (1) | 16 |
Impairment charges | 7 | — | 15 | 24 |
Other loss (gain) | (5) | 10 | (57) | 15 |
Restructuring costs | 4 | 6 | 9 | 12 |
Loss (gain) on derivative financial instruments | — | (4) | 10 | (4) |
Operating income | 78 | 73 | 217 | 159 |
Financing expenses | 31 | 35 | 90 | 104 |
Share of results of associates and joint ventures | (5) | (5) | (11) | (11) |
Earnings before income taxes | 52 | 43 | 138 | 66 |
Provision for income taxes | 15 | 8 | 29 | 16 |
Net earnings including non-controlling interests for the period | 37 | 35 | 109 | 50 |
Net earnings attributable to non-controlling interests | 7 | 6 | 19 | 17 |
Net earnings attributable to Shareholders for the period | 30 | 29 | 90 | 33 |
Net earnings per common share | ||||
Basic | $0.30 | $0.29 | $0.89 | $0.33 |
Diluted | $0.30 | $0.29 | $0.89 | $0.33 |
Weighted average basic number of common shares outstanding | 101,645,979 | 101,257,276 | 101,426,885 | 101,135,376 |
Weighted average number of diluted common shares | 102,736,811 | 101,338,740 | 102,147,719 | 101,309,725 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
For the 3-month periods | For the 9-month periods | |||
(in millions of Canadian dollars) (unaudited) | 2026 | 2025 | 2026 | 2025 |
Net earnings including non-controlling interests for the period | 37 |
|
||
Do not sell my personal information